Task: Answer the following question about the molecule with SMILES COc1ccnc(C[S+]([O-])c2nc3cc(-n4cccc4)ccc3[nH]2)c1C.
Request: Is it known if this drug is the first approved in its class, regardless of the indication or route of administration, acting on a specific target?
Answer: No
Task: Answer the following question about the molecule with {SMILES__description} {SMILES#}.
{#Description|Question|Request!}: {quest#}
{#Result|Answer|Completion!}: {answ#}
COc1ccnc(C[S+]([O-])c2nc3cc(-n4cccc4)ccc3[nH]2)c1C
COc1ccnc(C[S+]([O-])c2nc3cc(-n4cccc4)ccc3[nH]2)c1C
(4-methoxy-3-methyl-pyridin-2-yl)methyl-oxidanidyl-(5-pyrrol-1-yl-1H-benzimidazol-2-yl)sulfanium
Is it known if this drug is the first approved in its class, regardless of the indication or route of administration, acting on a specific target?
No